Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Properly Label and Store Multi-Dose Insulin Pens

Wilkes Barre, Pennsylvania Survey Completed on 06-12-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to comply with accepted standards for the labeling and storage of multi-dose medications, as observed during a review of a medication cart on the C Hall unit. Specifically, one multi-dose insulin pen of Insulin Lispro and two multi-dose pens of Insulin Glargine were found opened and in use without being labeled with the date they were initially opened, contrary to facility policy and manufacturer guidelines. Additionally, one Insulin Glargine pen was labeled with an opening date but was still in use past its recommended 28-day discard date. These deficiencies were confirmed through observation in the presence of an LPN and further verified during interviews with both the LPN and the Nursing Home Administrator. The facility's own policy requires opened multi-use vials or bottles to be dated to ensure proper tracking for expiration, and manufacturer instructions specify discard timelines for insulin pens. The failure to date and timely discard these medications resulted in non-compliance with state pharmacy and nursing service regulations.

An unhandled error has occurred. Reload 🗙